|
|
Merck & Co Inc CDR
TSX •
Healthcare •
Drug Manufacturers - General •
Quote as of 10/30/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeTSX
Market Capitalization506,047 mln
Float15,262 mln
Earnings Date10/29/2026
P / E
151
Highly speculative
Relative Strength
84
/ 100
Strongly outperforming
Key Fundamentals
EPS0.22
P/E151
ROE5.08
ROIC6.65
ROA1.91
Interest Cover8.72
EBITDA, mln16,300
EV / EBITDA35.69
EV / EBIT67.32
Revenue, mln93,254
EV / Revenue6.19
Quote Details
Last
33.14
Change
0.71 (2.19%)
Open
33.39
Volume
15,919
Turnover
527,556
Average Volume
25,863
Financial Ratios
Pre-Tax Profit Margin7
Leverage Ratio3.10
Current Ratio1.32
Price / Book8.80
Price / Cash Flow18.56
Price / Free Cash Flow23.12
Debt / Equity1.29
Price / Sales5.51
PEG Ratio3.11
Financial Strength
Altman Z-Score3.99
Piotroski F-Score
5
/ 9
Beneish M-Score-3.04
Price to Intrinsic Value2.22
Price to Lynch Fair Value4.82
Shiller PE Ratio38.40
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
2.76% |
90
/ 100
 |
| 1 Month |
2.54% |
77
/ 100
 |
| 2 Months |
14.64% |
89
/ 100
 |
| 6 Months |
31.38% |
95
/ 100
 |
|
| |
